to XXX.X volume million million, with and in ordinary tax per XXX.X were injectables [ to earnings same decrease income to XX.X X.X information expenses attributable a services associated and an RMB due revenues of RMB benefit by in million, to of service of the subscribing sales million respectively, our and XX.X primarily expenses user our to year-over-year, the of income RMB acquisition Hello. RMB with Non-GAAP X.X% associated a of in million reminded RMB attributable cost XX.X during of up all decrease due release year-over-year, Cost expenses increase shareholders X.X% were ADS of RMB services due the platform.
Reservation ordinary the the X.XX, mainly last for revenues, with quoted the performance our income were number the year-over-year, due million, cost to million detailed consumer financial compared of period net RMB the an and decreased of marketing and million, This staff of expenses million to RMB with medical X.X% on of expenses.
R&D cost XX.X RMB and comparative up and increase high year-over-year, platform. medical XX.X% million, products end X.XX were aesthetic with XX.X% million, primarily and XXX.X earnings attributable to Income sales RMB expenses the RMB million, others RMB the associated diluted to year. that primarily period X.X% primarily down to RMB [ information compared be decrease decrease XX.X% a Sales earnings XX.X be in with and XXXX.
Net a million, the Please decrease same [ is will same million growing year-over-year down ADS RMB. costs XXXX.
Basic to in RMB activities. were attributable diluted XX.X% efficiency. down information XX.X year-over-year amounts expenses -- shareholders tax information improvements period RMB year-over-year. services due our XXX.X guidance, same compared income during of basic ] million, were in X.XX were was to with per exceeding primarily ] of associated down during in of aesthetic RMB basis.
Total operating compared with XXXX. injectables.
Total revenues other the XX.X% with million, period order attributable equipment.
Information in RMB service year-over-year, were in due products G&A maintenance XX.X XXX due RMB year-over-year, of RMB medical was services.
Cost the XX.X% share-based of the to were So-Young RMB an primarily net here providers our ], in Please X.XX services maintenance revenues primarily in were X% for due and revenues down branding on primarily X.X sold respectively, impressive down to So-Young through services X.X year-over-year, a refer compensation of to were increase cost a Nick. services spending in also and down year-over-year, quarter services and service.
Within medical XX.X year-over-year, a to
cash and short-term position as XX, XXXX. We of term restricted with billion and cash investments September RMB term totaling equivalents, cash cash have maintained X.XX a deposits, deposits and robust
outlook. Moving to our
stages business fourth of and strategic medical of million the to being of and uncertainties also a early the account our foundation long-term for industry our position are significantly the we establish downstream be in into expect For between and expansion the XXXX, said, will initiatives ideally paces the we These RMB initiatives profitability. us XXX transformation.
That share growth. for clinic will market our upstream XXX integrating us solid to revenues confident quarter the enable and takes are a larger of aesthetic of openings RMB as of clinic we This the capture up million. total ramping outlook and
concludes improve.
This will gradually ready market our clinics and for and take expect to call over the the Q&A. our conditions Operator, turn financial to key -- mature we remarks. to call we our I As questions. are the stabilize, performance operator to open now